Acipimox/Rosuvastatin Calcium

้˜ฟๆ˜”่Žซๅธ/็‘ž่ˆ’ไผไป–ๆฑ€้’™

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAcipimox/Rosuvastatin Calcium
Drug Alias Name็‘ž่ˆ’ไผไป–ๆฑ€้’™+้˜ฟๆ˜”่ŽซๅธAcipimox+Rosuvastatin Calcium้˜ฟๆ˜”่Žซๅธ+็‘ž่ˆ’ไผไป–ๆฑ€้’™Rosuvastatin Calcium/Acipimox็‘ž่ˆ’ไผไป–ๆฑ€้’™/้˜ฟๆ˜”่Žซๅธ +[8]ย 
ClassificationSmall molecules
Mechanisms of ActionHMG-CoA reductase inhibitorsHydroxycarboxylic acid receptor 2 agonists
TargetsHMG-CoA reductaseHydroxycarboxylic acid receptor 2
Therapy Area/IndicationsHyperlipidemia, Familial Combined
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes AcipimoxRosuvastatin Calcium
Global Highest StatusPending (IND)
Highest Status in ChinaPending
Originator CompaniesLunan Pharmaceutical Group CoTeam Academy Of Pharmaceutical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTeam Academy Of Pharmaceutical SciencesLunan Better Pharmaceutical Co LtdShandong New Time Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsHyperlipidemia, Familial Combined

Other Information

ATC CodeN/A
Related LinksN/A